The Bridge is also not the appropriate coverage route when a GLP-1 medication is prescribed for certain conditions that may qualify for regular Part D coverage, including: Type 2 diabetes Moderate-to-severe obstructive sleep apnea Certain forms of fatty liver disease Patients receiving treatment for these conditions should speak with their health care provider and Medicare drug plan about regular Part D coverage
Beauty brands see a new consumer need and new wallets to tap
Tirzepatide, meanwhile, is an established treatment with proven clinical outcomes and FDA-approved indications
Presented for research literature review only Bernal V et al
You may notice changes in how you respond to diet and exercise: for instance, less hunger, smaller portions, fewer cravings, and more rapid fat loss (especially if you pair it with your current healthy habits)
Frontiers in physiology, 11, 694